Clinical Trial Update: Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study [EARLY_Phase 1]

View source ↗

Summary

A multicenter Phase 1 study assessing safety and efficacy of combining docetaxel, darolutamide, and homoharringtonine with androgen deprivation therapy as neoad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• DOCETAXEL (DOCETAXEL)
• Darolutamide (darolutamide)
• Homoharringtonine (homoharringtonine)

Snippet

Sponsor: Zhongda Hospital | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING